Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Non Operating Income (2019 - 2025)

Bioadaptives' Non Operating Income history spans 7 years, with the latest figure at -$575229.0 for Q4 2025.

  • Quarterly results put Non Operating Income at -$575229.0 for Q4 2025, down 1569.8% from a year ago — trailing twelve months through Dec 2025 was -$515725.0 (down 73.6% YoY), and the annual figure for FY2025 was -$515725.0, down 73.6%.
  • Non Operating Income for Q4 2025 was -$575229.0 at Bioadaptives, down from -$113813.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $138337.0 in Q3 2021 to a low of -$575229.0 in Q4 2025.
  • The 5-year median for Non Operating Income is -$89003.5 (2023), against an average of -$109193.9.
  • The sharpest move saw Non Operating Income skyrocketed 1135.48% in 2021, then tumbled 21081.23% in 2023.
  • Year by year, Non Operating Income stood at -$36549.0 in 2021, then soared by 97.33% to -$975.0 in 2022, then tumbled by 21081.23% to -$206517.0 in 2023, then skyrocketed by 83.32% to -$34449.0 in 2024, then tumbled by 1569.8% to -$575229.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$575229.0, -$113813.0, and $121305.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.